Assignee
HEXAL AG
DE·40 granted patents·18 pending applications·980 citations·filing 1994–2021
Top patents by PatentIndex Score
58 records- 0192US6284269B1Pharmaceutical compositions of meloxicam with improved solubility and bioavailabilityHEXAL AG·Filed 1998·Granted Sep 4, 2001·246 cites·22 claims
- 0289US6248758B1Pharmaceutical antacidHEXAL AG·Filed 1998·Granted Jun 19, 2001·108 cites·28 claims
- 0389US6022852APharmaceutical composition containing cyclosporin AHEXAL AG·Filed 1998·Granted Feb 8, 2000·92 cites·6 claims
- 0483US7344733B2Matrix controlled transdermal therapeutic system for the use of pramipexole and ropiniroleHEXAL AG·Filed 2002·Granted Mar 18, 2008·39 cites·13 claims
- 0583US6623752B1Patch for transdermal application for pergolidHEXAL AG·Filed 2000·Granted Sep 23, 2003·24 cites·8 claims
- 0682US6303141B1Transdermally administrable medicament with ACE inhibitorsHEXAL AG·Filed 1999·Granted Oct 16, 2001·53 cites·22 claims
- 0779US7220473B2Absorbing agents and cover layer which is impermeable to active substances and which contains channel-formers or removable protective layer of a transdermal therapeutic systemHEXAL AG·Filed 2001·Granted May 22, 2007·23 cites·8 claims
- 0876US5856359AThyroxine/cyclodextrin complexes and pharmaceutical compositions containing the sameHEXAL AG·Filed 1996·Granted Jan 5, 1999·47 cites·16 claims
- 0975US6579536B1Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredientHEXAL AG·Filed 1999·Granted Jun 17, 2003·56 cites·13 claims
- 1074US5738869ATransdermal drug preparationHEXAL AG·Filed 1994·Granted Apr 14, 1998·54 cites·7 claims
- 1171US6267990B1Controlled-release pharmaceutical preparation comprising an ACE inhibitor as active ingredientHEXAL AG·Filed 1999·Granted Jul 31, 2001·35 cites·36 claims
- 1271US5904930ATransdermal system in the form of a patch comprising a tamoxifen derivativeHEXAL AG·Filed 1997·Granted May 18, 1999·37 cites·14 claims
- 1370US11123300B2Immediate release tablet of a benzothiophene compoundHEXAL AG·Filed 2017·Granted Sep 21, 2021·1 cites·17 claims
- 1469US6395297B1Transdermal preparation contacting a loratidine metabolite with antihistaminic activityHEXAL AG·Filed 2000·Granted May 28, 2002·1 cites·10 claims
- 1566US6696413B2Pharmaceutical preparation with cyclosporin AHEXAL AG·Filed 1998·Granted Feb 24, 2004·26 cites·28 claims
- 1663US2008113012A1Method for using transdermal system with fentanylHEXAL AG·Filed 2008·Application pending·0 cites
- 1762US9789112B2Oral pharmaceutical film formulation for bitter tasting drugsHEXAL AG·Filed 2016·Granted Oct 17, 2017·1 cites·22 claims
- 1862US6537970B1Pharmaceutical compositionHEXAL AG·Filed 1998·Granted Mar 25, 2003·31 cites·12 claims
- 1958US2018067124A1Method of mapping glycans of glycoproteinsHEXAL AG·Filed 2017·Application pending·0 cites
- 2055US2022119471A1Glycoprotein with reduced acetylation rate of sialic acid residuesHEXAL AG·Filed 2021·Application pending·0 cites
- 2154US7690494B2Conveyor device having a filling device for vertical flow of material, without demixing, of powdered mediaHEXAL AG·Filed 2005·Granted Apr 6, 2010·7 cites·3 claims
- 2253US5972376ATransdermal system of tacrine/selegilin-plasterHEXAL AG·Filed 1996·Granted Oct 26, 1999·15 cites·25 claims
- 2353US2004001882A1Transdermal system with fentanylHEXAL AG·Filed 2003·Application pending·0 cites
- 2450US5874107ASustained release tablet containing diclofenac-Na and methylhydroxypropyl-cellulose as a sustained release agentHEXAL AG·Filed 1995·Granted Feb 23, 1999·12 cites·5 claims
- 2549USD600353SCovering materialHEXAL AG·Filed 2006·Granted Sep 15, 2009·7 cites·1 claims
- 2648US9895497B2Method for reducing leachables and extractables in syringesHEXAL AG·Filed 2014·Granted Feb 20, 2018·0 cites·7 claims
- 2748US6440513B1Flat transdermal medicated self-adhesive patchHEXAL AG·Filed 1997·Granted Aug 27, 2002·26 cites·23 claims
- 2846US5989585ATransdermal therapeutic system (TTS) containing vitamin E for the treatment of drug dependencyHEXAL AG·Filed 1996·Granted Nov 23, 1999·12 cites·12 claims
- 2946US2009186341A1Receptacle for the Separation of Tumor CellsHEXAL AG·Filed 2006·Application pending·0 cites
- 3045US2024052030A1Novel formulations for antibodiesHEXAL AG·Filed 2021·Application pending·0 cites
- 3144US10485799B2Pharmaceutical composition of vortioxetine hydrobromide comprising vortioxetine hydrobromide in a polyethylene oxide matrixHEXAL AG·Filed 2016·Granted Nov 26, 2019·0 cites·9 claims
- 3244US6204255B1Solid, non-deliquescent formulations of sodium valproateHEXAL AG·Filed 1998·Granted Mar 20, 2001·7 cites·14 claims
- 3344US2018042861A1Transdermal therapeutic system comprising buprenorphrineHEXAL AG·Filed 2017·Application pending·0 cites
- 3444US2016151484A1Methods and formulations which allow the modulation of immune responses related to the administration of a biopharmaceutical drugHEXAL AG·Filed 2014·Application pending·0 cites
- 3543US11072605B2Crystalline brexpiprazoleHEXAL AG·Filed 2018·Granted Jul 27, 2021·0 cites·12 claims
- 3642US10668073B2Pharmaceutical composition containing 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione or a pharmaceutically acceptable salt thereofHEXAL AG·Filed 2016·Granted Jun 2, 2020·0 cites·17 claims
- 3741US2016199293A1Method for manufacturing an ingestible film, apparatus for manufacturing an ingestible film, ingestible film and pharmaceutical dosage form comprising the sameHEXAL AG·Filed 2014·Application pending·0 cites
- 3840US2019025323A1Methods of Mapping Protein VariantsHEXAL AG·Filed 2017·Application pending·0 cites
- 3939USD634850SCovering materialHEXAL AG·Filed 2007·Granted Mar 22, 2011·3 cites·1 claims
- 4039US2015366807A1Oral pharmaceutical composition comprising dabigatran etexilateHEXAL AG·Filed 2013·Application pending·0 cites
- 4139US2009023714A1Combined preparation of a thiazide diuretic and a loop diureticHEXAL AG·Filed 2006·Application pending·0 cites
- 4238US6071964ADiclofenac/gamma-cyclodextrin inclusion compoundsHEXAL AG·Filed 1997·Granted Jun 6, 2000·9 cites·14 claims
- 4337US6165498ATransdermal preparation containing a loratidine metabolite with antihistaminic activityHEXAL AG·Filed 1995·Granted Dec 26, 2000·3 cites·6 claims
- 4437US2019177385A1Glycoprotein with reduced acetylation rate of sialic acid residuesHEXAL AG·Filed 2017·Application pending·0 cites
- 4537US2017205423A1Method of Mapping Glycans of Glycoproteins in Serum SamplesHEXAL AG·Filed 2015·Application pending·0 cites
- 4636USD636882SCovering materialHEXAL AG·Filed 2010·Granted Apr 26, 2011·2 cites·1 claims
- 4734US9717707B2Pharmaceutical statin compositionHEXAL AG·Filed 2012·Granted Aug 1, 2017·0 cites·21 claims
- 4834US2016129113A1Tablets comprising a taste masking agentHEXAL AG·Filed 2015·Application pending·0 cites
- 4934US2014363516A1Multiple unit pellet tablet formulation comprising an opioidHEXAL AG·Filed 2012·Application pending·0 cites
- 5032US11021530B2Antibody preparationHEXAL AG·Filed 2017·Granted Jun 1, 2021·0 cites·8 claims
Showing the top 50 of 58 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →